HIGHLIGHTS
- who: Keng Po Lai from the Institute of Oncology Guilin People`s Hospital, China The Pharmaceutical Department, The Second Affiliated Hospital of Guangxi Medical University have published the research: Therapeutic targets and functions of curcumol against COVID-19 and colon adenocarcinoma, in the Journal: (JOURNAL) of June/20,/2022
- what: In the second part of the study , the authors focused on the functional roles of the curcumol targets.
- how: The results showed that the expression of GABRD was significantly associated with the hazard ratio of COAD (Supplementary Table 2). The data indicated that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.